Feed MRNA
MR
Moderna
MRNA · NASDAQ
$59.17 +7.99% (+$4.38)
1M -29.65%
Market Cap $21.4B
P/E Ratio -
Div. Yield -
ROE 32.45%
Valuation
38 /100
Fair P/B 2.47x
P/S 10.99x
P/FFO N/A
Growth
0 /100
Declining Book val. growth 23.24%
Rev. growth 53.13%
FCF growth N/A
Profitability
20 /100
Weak Op. margin 158.13%
Gross margin 55.35%
FCF margin 106.22%
Quality
2 /100
Poor ROA 22.87%
ROIC 30.28%
Asset turnover 0.16x
Debt
100 /100
Low Current ratio 3.29x
Debt/Equity 0.22x
Debt/Assets N/A
Stability
49 /100
Moderate EPS volatility 106.63%
Beta 0.94x
Profitable years 0
Întreabă StockBot despre MRNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stéphane Bancel
Employees
4,700
Headquarters
Cambridge
Evenimente viitoare
05 NOV.
Earnings
Upcoming earnings report